Clinical Trial Update: Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)? [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigated whether adding divalproex sodium ER to an atypical antipsychotic improves cognition and psychopathology in outpatients with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Atypical antipsychotic (unspecified)
• Divalproex Sodium ER (divalproex sodium ER)

Snippet

Sponsor: Northwestern University | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED | Results posted: 2025-06-27